Physician profile
Thomas L Meyer
NPI 1487658829
$1,887.13
in general payments reported to CMS, 2019-2025
24 companies · $19.00 in 2025
The $19.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $188 · 2021: $400 · 2022: $591 · 2023: $266 · 2024: $249 · 2025: $19.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275 · Travel and Lodging: $193 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.58 |
| Travel and Lodging | $193.37 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $448.79 | 2022-2025 | |
| Abbvie INC. | $306.22 | 2019-2023 | |
| Myovant Sciences INC. | $171.46 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $171.35 | 2020-2023 | Xifaxan |
| Astellas Pharma US INC | $125.20 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $107.42 | 2023-2024 | Myfembree |
| Aspira Women'S Health INC | $64.37 | 2020-2021 | |
| Pfizer INC. | $59.74 | 2019-2024 | |
| Evofem Biosciences, INC. | $50.48 | 2021 | |
| Daiichi Sankyo INC. | $48.86 | 2019-2022 | |
| Therapeuticsmd, INC. | $46.39 | 2019-2022 | |
| Ascend Therapeutics US, LLC | $45.40 | 2021-2022 | |
| Hologic Sales and Service, LLC | $45.19 | 2020-2021 | |
| Avion Pharmaceuticals | $39.32 | 2019-2023 | Balcoltra |
| Organon LLC | $23.27 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $18.40 | 2019 | |
| Merck Sharp & Dohme LLC | $17.62 | 2021 | |
| Mayne Pharma Commercial LLC | $17.10 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.97 | 2021 | |
| Dysis Medical, INC. | $15.12 | 2020 | |
| Medtronic, INC. | $14.91 | 2023 | Ligasure |
| Duchesnay USA Incorporated | $11.33 | 2019 | |
| Acessa Health INC. | $11.28 | 2019 | |
| Lupin INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.